Beta Bionics announced it received U.S. Food and Drug Administration (FDA) clearance for Mint, its insulin patch pump with reusable and disposable components. The tubeless pump can be controlled ...

Senseonics is integrating the Eversense 365 continuous glucose monitor with Beta Bionics’ iLet Bionic Pancreas automated insulin delivery system. The companies said the integrated device will combine ...

If a beatdown comes with great responsibility, you'd better be in the proper outfit! A closer look to the Advanced Suit 2.0, inspired by Marvel's Spide-Man 2! Included with the MARVEL Tōkon: Fighting ...

The Spider-Man Advanced Suit 2.0 suit, inspired by Marvel Spider-Man 2, takes the spotlight in this latest Marvel Tōkon: Fighting Souls trailer for the upcoming 4v4 Tag-Team fighting game. Marvel ...

New FDA inclusion criteria expands candidacy for single-sided deafness. For patients with asymmetric hearing loss, this new criteria represents the broadest candidacy range in the industry, helping ...

VALENCIA, CA / ACCESS Newswire / July 28, 2026 / Advanced Bionics, a global leader in cochlear implant technology and a Sonova brand, today announced expanded U.S. Food and Drug Administration ...

AI success depends on whether enterprise data is ready, reachable, and close enough to the workloads that need it. In this eSpeaks episode, Dell Technologies’ Vrashank Jain explains why fragmented ...

Humanoids and humans are increasingly sharing factory floors, but one is made of metal and the other of flesh and bones, a mismatch that rarely ends well for us in a collision. Italian startup ...

On Dec. 27, 2024, a skiing accident left New Mexico-resident Ulrich John paralyzed. He had been a professional skier and was simply giving his son a ski lesson on a green run when he suddenly lost his ...

We are featuring the products that won the Radio World Best of Show Award at the 2026 NAB Show. Winners were chosen by a panel of engineers and RW editorial staff for their innovation, feature set, ...

Spiral Therapeutics, a clinical-stage biotechnology company developing therapies for inner ear disorders, announced the close of a $27 million Series B financing alongside a strategic research and ...